Medorrhinum (Granules) Instructions for Use

Marketing Authorization Holder

Boiron (France)

Contact Information

BOIRON (France)

ATC Code

V30 (Not assigned)

Dosage Forms

	Medorrhinum	Homeopathic granules C5: 4 g tube with granule counter
		Homeopathic granules C9: 4 g tube with granule counter
		Homeopathic granules C15: 4 g tube with granule counter
		Homeopathic granules C30: 4 g tube with granule counter

Dosage Form, Packaging, and Product Composition

Excipients: sucrose, lactose.

4 g – tubes with granule counter (1) – cardboard packs.

Clinical-Pharmacological Group

Single-component homeopathic preparation of animal origin

Pharmacotherapeutic Group

Homeopathic agent

Pharmacological Action

This medicinal product is made from a lysate of urethral discharge from patients with gonorrhea, taken before the start of treatment. It is manufactured in compliance with viral safety rules^*.

^*donors are selected according to safety and health criteria approved by AFFSAP (French Agency for the Safety of Health Products) for marketing authorizations for medicinal products manufactured from donor material. These criteria comply with European guidelines.

Indications

Key symptoms for prescribing the drug

• Growth of cutaneous-mucosal neoplasms: molluscum, condylomas, warts;
• Abundant serous discharge from orifices, especially the vagina in women;
• Presence of catarrhal inflammation in one or more mucous membranes;
• Slowly progressive development of various diseases;
• Tendency to depression and even obsession, as a reaction to existing diseases.

Main cases of clinical application

Otorhinolaryngology

• Chronic rhinopharyngitis with enlarged adenoids, which may be hypertrophic or not, abundant, clear discharge;
• Exudative otitis media;
• Prevention of sore throat recurrence;
• Chronic sinusitis, nasal and sinus polyposis.

Pulmonology

• Chronic bronchitis;
• Treatment of chronic asthma.

Dermatology

• Diaper dermatitis;
• Unpleasantly smelling weeping eczema;
• Herpes, especially genital;
• Acne;
• Small warts, plantar warts, confluent warts on the cheeks;
• Molluscum contagiosum, condylomas, papillomas.

Urology

• Protracted urinary tract infections;
• Chronic prostatitis;
• Prevention of bladder polyposis recurrence.

Gynecology

• Chronic vaginitis;
• Gynecological infections, in particular:
  • HPV infections;
  • Chlamydia: a primary indication, because in this disease there is an identical location of lesions, both urethrovaginal and conjunctival, and pathogenetic symptoms characteristic of this substance;
• Uterine fibroids and intrauterine polyps: to limit disease progression and prevent recurrence after their removal in women with recurrent urogenital infections.

Rheumatology

• Degenerative or inflammatory rheumatism, especially in large joints with characteristic changes, pelvic rheumatoid spondylitis;
• Reactive arthritis, especially if there is a history of Flessinger-Leroy-Reiter syndrome, the symptoms of which are similar to the pathogenetic symptoms of Medorrhinum (Medorrhinum).

Behavioral disorders

• Sleep disorders in children who make rhythmic head movements on the pillow when falling asleep, sleep on their stomach or in a knee-elbow position;
• Difficulties with learning at school due to memory problems or psychomotor agitation with disorderly accelerated movements;
• Some depressive and/or obsessive states. Medorrhinum (Medorrhinum) has been used to treat depressive and/or obsessive states in adults following a chronic urogenital infection requiring long-term treatment.

Dosage Regimen

Sublingually.

The granules should be dissolved in the mouth 30 minutes before a meal or 60 minutes after a meal.

For children from 0 to 3 years old, the granules are first diluted by shaking in 10-15 ml of water at room temperature and given to drink.

The optimal amount per dose is 5 granules.

Consultation with a doctor is necessary to determine the potency, frequency and duration of administration.

Adverse Reactions

None described to date.

Contraindications

• Individual hypersensitivity to the drug;
• Lactose intolerance.

Special Precautions

The dosage regimen and frequency of administration are determined by the doctor.

If there is no therapeutic effect within 3 days, or if adverse reactions occur, you should consult a doctor.

Overdose

No information on overdose cases has been received to date.

Drug Interactions

Other medications can be used concomitantly with Medorrhinum.

Storage Conditions

At a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life – 5 years.

Dispensing Status

The drug is available without a prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.